Search filters

List of works by Suresh K Agarwal

A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics

scientific article published on 17 November 2016

A pilot study assessing pharmacokinetics and tolerability of oral and intravenous baclofen in healthy adult volunteers

scientific article published on 14 July 2014

A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers.

scientific article published on 2 April 2013

Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis.

scientific article published on 27 May 2016

Development of benzodiazepines for out-of-hospital management of seizure emergencies.

scientific article published in February 2015

Effect of Azithromycin on Venetoclax Pharmacokinetics in Healthy Volunteers: Implications for Dosing Venetoclax with P-gp Inhibitors

scientific article published on 27 September 2018

Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor.

scientific article published on 31 March 2016

Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma.

scientific article published on 2 November 2016

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

scientific article

Evaluation of Rifampin's Transporter Inhibitory and CYP3A Inductive Effects on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor: Results of a Single- and Multiple-Dose Study

scientific article published on 7 March 2016

Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers

scientific article published on 2 December 2016

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites.

scientific article

Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma.

scientific article published on 25 August 2016

Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Healthy Chinese Subjects.

scientific article

Pharmacokinetics of venetoclax in patients with 17p deletion chronic lymphocytic leukemia.

scientific article published in September 2017

Statins enhance efficacy of venetoclax in blood cancers.

scientific article published in June 2018

Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy

scientific article

Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study

scientific article

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study

scholarly article by S de Vos et al published 1 September 2018 in Annals of Oncology

Paulina is supported by:

About Paulina

Help